Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.596
-0.014 (-2.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MTNB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -10.35 | -24.25 | -22.94 | -21 | -23.28 | |
| Depreciation & Amortization | 0.46 | 0.97 | 0.94 | 0.9 | 0.78 | |
| Other Amortization | - | - | - | 0.21 | 0.25 | |
| Loss (Gain) From Sale of Assets | -0.04 | - | 0 | 0 | 0 | |
| Asset Writedown & Restructuring Costs | - | 4.43 | - | - | - | |
| Stock-Based Compensation | 1.02 | 3.2 | 4.95 | 5.23 | 4.29 | |
| Other Operating Activities | 3.4 | -0.1 | 0.11 | 0.29 | 1.2 | |
| Change in Accounts Payable | 0.22 | -0.42 | -0.1 | -0.32 | 0.59 | |
| Change in Other Net Operating Assets | -1.73 | 0.29 | 1.77 | -4.47 | 0.95 | |
| Operating Cash Flow | -7.01 | -15.89 | -15.28 | -19.16 | -15.22 | |
| Capital Expenditures | - | - | -0.22 | -0.89 | -0.26 | |
| Sale of Property, Plant & Equipment | 0.34 | - | - | - | - | |
| Investment in Securities | - | 9.21 | 13.46 | 5.77 | 17.03 | |
| Investing Cash Flow | 0.34 | 9.21 | 13.24 | 4.88 | 16.77 | |
| Long-Term Debt Repaid | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | |
| Total Debt Repaid | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | |
| Net Debt Issued (Repaid) | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | |
| Issuance of Common Stock | 0.13 | 9.18 | - | 0.1 | 7 | |
| Other Financing Activities | -0.03 | - | - | - | - | |
| Financing Cash Flow | 3.39 | 9.17 | -0.01 | 0.08 | 6.97 | |
| Net Cash Flow | -3.29 | 2.5 | -2.04 | -14.2 | 8.51 | |
| Free Cash Flow | -7.01 | -15.89 | -15.5 | -20.05 | -15.48 | |
| Free Cash Flow Margin | - | - | -1413.87% | -628.86% | -46918.18% | |
| Free Cash Flow Per Share | -1.28 | -3.27 | -3.57 | -4.62 | -3.68 | |
| Levered Free Cash Flow | -3.34 | -7.45 | -6.96 | -14.39 | -8.25 | |
| Unlevered Free Cash Flow | -3.34 | -7.45 | -6.96 | -14.6 | -8.5 | |
| Change in Working Capital | -1.51 | -0.13 | 1.67 | -4.79 | 1.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.